13 December 2018 08:46 CET

Karo Intressenter AB extends the acceptance period for its offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

Fore more information, click here.

Latest news

13 December 2024
EQT completes public offering of common stock of Kodiak Gas Services
13 December 2024
EQT Completes Acquisition of PropertyGuru
13 December 2024
EQT Exeter acquires two UK warehouses in Milton Keynes and Dartford
11 December 2024
EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million
06 December 2024
EQT Life Sciences leads Series A funding round for maternal health company Nua Surgical